세계의 담도 스텐트 시장 규모 조사 및 예측 : 재료별, 용도별, 최종사용자별, 지역별 분석(2023-2030년)

Global Biliary Stent Market is valued at approximately USD 394.5 million in 2022 and is anticipated to grow with a healthy growth rate of more than 5.5% over the forecast period 2023-2030. Biliary stents are medical devices that are used to treat various conditions related to the bile ducts, which are part of the digestive system. The bile ducts are responsible for transporting bile, a fluid produced by the liver that helps digest fats, from the liver to the small intestine. The Biliary Stent market is expanding because of factors such as increasing biliary duct disorders and growing elderly aged population. Biliary stents are typically made of metal or plastic and are inserted into the bile ducts to help maintain their patency or to provide drainage in cases where the normal flow of bile is obstructed. They can be used for both temporary and permanent purposes, depending on the underlying condition being treated. Its prevalence has progressively increased during the last few decades.

According to Statista, in 2020, distant metastasis was the most common form of liver and bile duct cancer among Thai cancer patients, accounting for 87 new cases. Males made up the majority of new patients with liver and bile duct cancer during the same year. Furthermore, as per the American Society of Clinical Oncology, approximately 8,000 persons in the United States are diagnosed with bile duct cancer each year. People with intrahepatic bile duct cancer are diagnosed at an average age of 70. Another important component driving space is increase in elderly aged population. As geriatric and obese populations are predisposed to chronic diseases. According to the World Bank Group, in 2020, the world's elderly population was 727 million, and it is expected to triple over the next three decades, reaching 1.5 billion in 2050. In addition, Japan has always been at the forefront in terms of the proportion of residents aged 65 and above, with almost 86,000 elderly individuals entirely living in the island nation in 2021. Also, rising adoption of minimally invasive medical equipment and growing pancreatic disorders would create a lucrative growth prospectus for the market over the forecast period. However, stringent government regulation stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Biliary Stent Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players in the region. According to the American Cancer Society, about 8,000 people in the United States are diagnosed with bile duct cancer each year. This includes both intrahepatic and extrahepatic bile duct cancer. Furthermore, Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric and target populations, and geographic expansion of key players in the market space.

Major market players included in this report are:

• Boston Scientific Corporation
• Medtronic plc
• Abbott Laboratories
• Biosensors International Group
• ENDO-FLEX GmbH
• Richard Wolf GmbH
• Olympus Corporation
• CONMED Corporation
• Becton, Dickinson and Company
• Stryker Corporation,

Recent Developments in the Market:

• In April 2023, Boston Scientific acquired Apollo Endosurgery, a medical technology firm that specializes in the design, development, and commercialization of less invasive medical devices that enable gastrointestinal therapeutic endoscopy and Endo bariatrics.

Global Biliary Stent Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Material, Application, End-User, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Material

• Metal
• Plastic

By Applications

• Malignant Obstruction
• Benign Biliary Strictures
• Biliary Leaks
• Others

By End-User

• Hospitals
• Specialty Clinics
• Diagnostic Laboratories
• Research and Academic Institutes
• Ambulance Surgical Centers
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1. Biliary Stent Market, by Region, 2020-2030 (USD Million)
  • 1.2.2. Biliary Stent Market, by Material, 2020-2030 (USD Million)
  • 1.2.3. Biliary Stent Market, by Applications, 2020-2030 (USD Million)
  • 1.2.4. Biliary Stent Market, by End-User, 2020-2030 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Biliary Stent Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Biliary Stent Market Dynamics

• 3.1. Biliary Stent Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing biliary duct disorders
    • 3.1.1.2. Growing elderly aged population
  • 3.1.2. Market Challenges
    • 3.1.2.1. Stringent government regulations
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising adoption of minimally invasive medical equipment
    • 3.1.3.2. Growing pancreatic disorders

Chapter 4. Global Biliary Stent Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Biliary Stent Market, by Material

• 5.1. Market Snapshot
• 5.2. Global Biliary Stent Market by Material, Performance - Potential Analysis
• 5.3. Global Biliary Stent Market Estimates & Forecasts by Material 2020-2030 (USD Million)
• 5.4. Biliary Stent Market, Sub Segment Analysis
  • 5.4.1. Metal
  • 5.4.2. Plastic

Chapter 6. Global Biliary Stent Market, by Applications

• 6.1. Market Snapshot
• 6.2. Global Biliary Stent Market by Applications, Performance - Potential Analysis
• 6.3. Global Biliary Stent Market Estimates & Forecasts by Applications 2020-2030 (USD Million)
• 6.4. Biliary Stent Market, Sub Segment Analysis
  • 6.4.1. Malignant Obstruction
  • 6.4.2. Benign Biliary Strictures
  • 6.4.3. Biliary Leaks
  • 6.4.4. Others

Chapter 7. Global Biliary Stent Market, by End-User

• 7.1. Market Snapshot
• 7.2. Global Biliary Stent Market by End-User, Performance - Potential Analysis
• 7.3. Global Biliary Stent Market Estimates & Forecasts by End-User 2020-2030 (USD Million)
• 7.4. Biliary Stent Market, Sub Segment Analysis
  • 7.4.1. Hospitals
  • 7.4.2. Specialty Clinics
  • 7.4.3. Diagnostic Laboratories
  • 7.4.4. Research and Academic Institutes
  • 7.4.5. Ambulatory surgical Centers
  • 7.4.6. Others

Chapter 8. Global Biliary Stent Market, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Biliary Stent Market, Regional Market Snapshot
• 8.4. North America Biliary Stent Market
  • 8.4.1. U.S. Biliary Stent Market
    • 8.4.1.1. Material breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Applications breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. End-User breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Biliary Stent Market
• 8.5. Europe Biliary Stent Market Snapshot
  • 8.5.1. U.K. Biliary Stent Market
  • 8.5.2. Germany Biliary Stent Market
  • 8.5.3. France Biliary Stent Market
  • 8.5.4. Spain Biliary Stent Market
  • 8.5.5. Italy Biliary Stent Market
  • 8.5.6. Rest of Europe Biliary Stent Market
• 8.6. Asia-Pacific Biliary Stent Market Snapshot
  • 8.6.1. China Biliary Stent Market
  • 8.6.2. India Biliary Stent Market
  • 8.6.3. Japan Biliary Stent Market
  • 8.6.4. Australia Biliary Stent Market
  • 8.6.5. South Korea Biliary Stent Market
  • 8.6.6. Rest of Asia Pacific Biliary Stent Market
• 8.7. Latin America Biliary Stent Market Snapshot
  • 8.7.1. Brazil Biliary Stent Market
  • 8.7.2. Mexico Biliary Stent Market
• 8.8. Middle East & Africa Biliary Stent Market
  • 8.8.1. Saudi Arabia Biliary Stent Market
  • 8.8.2. South Africa Biliary Stent Market
  • 8.8.3. Rest of Middle East & Africa Biliary Stent Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Boston Scientific Corporation
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. Medtronic plc
  • 9.3.3. Abbott Laboratories
  • 9.3.4. Biosensors International Group
  • 9.3.5. ENDO-FLEX GmbH
  • 9.3.6. Richard Wolf GmbH
  • 9.3.7. Olympus Corporation
  • 9.3.8. CONMED Corporation
  • 9.3.9. Becton, Dickinson and Company
  • 9.3.10. Stryker Corporation

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption